BGACF (BioNeutra Global) LT-Debt-to-Total-Asset: 0.49 (As of Sep. 2024)


What is BioNeutra Global LT-Debt-to-Total-Asset?

BioNeutra Global BGACF LT-Debt-to-Total-Asset is 0.49 as of Sep. 2024.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. BioNeutra Global's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.49.

BioNeutra Global's long-term debt to total assets ratio increased from Sep. 2023 (0.42) to Sep. 2024 (0.49). It may suggest that BioNeutra Global is progressively becoming more dependent on debt to grow their business.

BioNeutra Global  (OTCPK:BGACF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

BioNeutra Global LT-Debt-to-Total-Asset Related Terms

BioNeutra Global LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for BioNeutra Global's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNeutra Global LT-Debt-to-Total-Asset Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.27 0.30 0.34 0.46

BioNeutra Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.46 0.45 0.49 0.49

BioNeutra Global LT-Debt-to-Total-Asset Calculation

BioNeutra Global's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=5.35/11.752
=0.46

BioNeutra Global's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )/Total Assets (Q: Sep. 2024 )
=4.879/10.021
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.49 mean?
BioNeutra Global (BGACF) has a LT-Debt-to-Total-Asset of 0.49 as of Sep. 2024. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on BioNeutra Global and its competitors.
Is BioNeutra Global's LT-Debt-to-Total-Asset too high?
BioNeutra Global's current LT-Debt-to-Total-Asset is 0.49.
How does BioNeutra Global's LT-Debt-to-Total-Asset compare to ARRT and BSFC?
BioNeutra Global's LT-Debt-to-Total-Asset of 0.49 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Consumer Packaged Goods company?
A good LT-Debt-to-Total-Asset depends on the Consumer Packaged Goods industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on BioNeutra Global and its competitors. BioNeutra Global's current LT-Debt-to-Total-Asset is 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNeutra Global stock overvalued right now?
BioNeutra Global (BGACF) has a current LT-Debt-to-Total-Asset of 0.49. The current LT-Debt-to-Total-Asset is 0.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For BioNeutra Global (BGACF), the current LT-Debt-to-Total-Asset is 0.49 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioNeutra Global Business Description

Address 1101-1030 West Georgia Street, Vancouver, BC, CAN, V6E 2Y3
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.